FY21 Half Year Report
Filed with ASX · · 30 pages · English
Authorised for release by the Board of Directors of Cogstate Ltd. About Cogstate Cogstate Ltd (ASX:CGS) is a leading neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Cogstate technologies provide rapid, reliable and highly sensitive computerized cognitive tests across a growing lis
In the deck
Story so far
Earlier from Cogstate
- FY21 Half Year Results Announcement
- FY21 Half Year Result Presentation
- standalone clarification 2020-12 Quarterly Activity report
- Eisai Secures Global License to Cogstate Technologies
- standalone announcement Quarterly Activity Statement
Later from Cogstate
- Appendix 4C - quarterly
- Investor Presentation
- Business Update - approval of Alzheimers therapeutic
- Loan Forgiven re US Governments Paycheck Protection Program
- Value of FY21 Clinical Trials Sales Contracts up 15%
Follow Cogstate into a list and get an email when it puts out news.
Follow Cogstate